Skip to main content

Schobel Alexander Mark

Chief Innovation/ Tech Officer

1 company

Insider Signal Score

83
Excellent
Trades Analyzed
6
12M Win Rate
100.0%
Avg 3M Return
+47.0%
Avg 12M Return
+63.3%

Schobel Alexander Mark is a Chief Innovation/ Tech Officer at Aquestive Therapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 9 sells.

Estimated insider holdings value: $3.7M based on current market prices.

Holdings by Company

AQSTMar 15, 2024
Current Shares984.5K
Value$3.70M
Net Activity-260,921
Bought: 49.9KSold: 310.8K

Transaction History

Showing 10 filings
DateTickerRoleTypeSharesPriceValueChg%3M12MSEC
Mar 15, 2024
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell50,000$6.00$300,000.00-4.8%-54.5%-53.4%
Mar 8, 2024
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell25,000$5.19$129,685.00-2.3%-42.4%-45.7%
Jun 8, 2022
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerBuy45,871$0.96$44,036.16+5.5%+38.6%+138.4%
Feb 10, 2021
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell35,000$6.75$236,250.00-2.0%-50.2%-60.8%
Feb 8, 2021
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell40,792$6.50$265,148.00-4.5%-47.6%-61.0%
May 8, 2020
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell40,000$5.00$200,000.00-4.2%--
Apr 29, 2020
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell40,000$4.50$180,000.00-3.8%--
Apr 27, 2020
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerSell80,000$3.85$308,000.00-4.0%--
Dec 10, 2018
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerBuy1,000$7.78$7,780.00---
Dec 6, 2018
AQST
Aquestive Therapeutics, Inc.
Chief Innovation/ Tech OfficerBuy2,000$8.69$17,380.00+0.2%--
Page 1Next →